OS RISCOS DOS INIBIDORES DE APETITE: A SIBUTRAMINA

Abstract

The objective of this work is to analyze the risks of the appetite suppressant sibutramine and the role of the pharmacist in reducing the risk of using appetite suppressants. The goal in the weight loss process is to prevent or reduce obesity-associated morbidity and mortality by improving cardiovascular and metabolic risk factors. Unfortunately, there is little evidence that available weight-loss medications achieve this goal. Recently, concerns about patient safety have overtaken the evidence for the benefit of many weight-loss medications. The literature review method allows including experimental and non-experimental research, obtaining the combination of empirical and theoretical data that can lead to the definition of concepts, identification of gaps in the areas of study, review of theories and methodological analysis of studies on a particular topic. This method requires resources, knowledge and skills for its development.